Last reviewed · How we verify
NCT04326686: MI-DIET
Measuring Individual Responses to a Wholegrains and Nuts Intervention to Reduce Blood Pressure in Prehypertension
NA trial testing Dietary intervention: nuts and wholegrains with dietary advice for a blood-pressure lowering diet in Prehypertension in 12 participants. Completed in 25 March 2022.
25 March 2022
Quick facts
| Lead sponsor | University of Aberdeen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 12 |
| Start date | 30 October 2020 |
| Primary completion | 25 March 2022 |
| Estimated completion | 25 March 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Dietary intervention: nuts and wholegrains with dietary advice for a blood-pressure lowering diet
Conditions studied
- Prehypertension — all drugs for Prehypertension →
Sponsor
University of Aberdeen
Who can join
Adults 18 to 75, any sex, with Prehypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to investigate whether physiological, psychological and environmental factors, at an individual level, modify a) adherence, and b) blood pressure response, to a nuts and wholegrains intervention in participants at risk for developing high blood pressure. For 24 weeks, participants will, on a daily basis, monitor their own blood pressure using a wireless blood pressure monitor and respond to short semi-personalised questionnaires using a wrist-worn device, which also measures activity levels. Participants will receive an intervention of wholegrain foods and nuts to substitute into their diets for 8 weeks, between two 8-week observation periods. The length of the study periods will enable repeated measurements to be taken, in order to assess what factors, on an individual level, are associated with fluctuations in the outcomes. This will provide an insight into the types of factors that can help to explain individual fluctuations in adherence and physiological outcomes, such as blood pressure, that are common in nutrition studies. In the future, this should help in tailoring the way the investigators deliver effective individualised interventions, and enable researchers to be better able to consider and control for factors that can affect adherence and response to dietary interventions.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Perspective: Application of N-of-1 Methods in Personalized Nutrition Research.
Potter T, Vieira R, de Roos B. · · 2021 · cited 27× · PMID 33460438 · DOI 10.1093/advances/nmaa173 -
A series of N-of-1 dietary intervention studies with whole-grain foods and nuts reveals individual predictors of blood pressure and heart rate.
Potter TIT, Pepping F, Wanders AJ, Zandstra EH, et al · · 2026 · PMID 42049896 · DOI 10.1038/s41430-026-01740-3
Verify or expand the search:
- PubMed search for NCT04326686
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prehypertension
Currently open trials in the same condition.
- NCT07372729 — Smartwatch-based Intervention for Cardiovascular Health (SWITCH) · NA · recruiting
- NCT06762262 — Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients · NA · active not recruiting
- NCT05469503 — Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure · NA · active not recruiting
- NCT06595251 — Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study · recruiting
- NCT06596265 — Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study · recruiting
Other University of Aberdeen trials
Trials by the same sponsor.
- NCT07070765 — Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity · NA · not yet recruiting
- NCT07065383 — Rebalancing the Fat Content of the Heart and Muscles · NA · recruiting
- NCT06735573 — Protein, Sarcopenic Obesity, and COPD · not yet recruiting
- NCT06714656 — Drivers and Barriers for Adopting Healthy and Sustainable Food Swaps in Young · NA · recruiting
- NCT06721312 — Continuous Heart Rate Variability Monitoring in Doctors; Understanding Patterns of Stress and Recovery and Their Relatio · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04326686 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Aberdeen
- Last refreshed: 17 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04326686.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing